Respondents were more satisfied, felt more cared for, and found messages more useful if they came from AI rather than humans. “Participants preferred AI-drafted messages, which tended to be longer, ...

Patients with severe obesity and those who had undergone bariatric surgery are at increased risk for developing inflammatory bowel disease. Incident inflammatory bowel disease (IBD) risk was found to ...

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Patients with type 2 diabetes and comorbid lung function impairment had higher risks for cardiovascular disease and mortality. Individuals with type 2 diabetes (T2D) and comorbid lung function ...

Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.

Researchers saw more frequent placements of central venous catheters and inpatient dialysis for patients with CKD and heart failure. HealthDay News — Patients with chronic kidney disease (CKD) and ...